Trial Profile

Non-Interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Aug 2021 Results (n=66) assessing effectiveness with a special focus on duration of response (DOR), safety and utilization of vismodegib for treatment of locally advanced basal cell carcinoma, in daily practice in Germany, published in the Journal of the European Academy of Dermatology and Venereology.
10 May 2019 Status changed from active, no longer recruiting to completed.
02 Oct 2017 Planned End Date changed from 1 Mar 2019 to 31 Mar 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com